Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like <b>VANC Pharmaceuticals</b> Announces Non Brokered Private Placement July 20, 2017 PPD Clinical Research Associates Recognized For Excellence June 8, 2017 Siemens Summons Three Banks for IPO of Healthineers Unit October 25, 2017
